Evidence map›Paper›PMID 29740235›Full record

ArticleSaudi journal of biological sciences2018

Effect of lipid lowering tablet on blood lipid in hyperlipidemia model rats.

Xuejun Kong, Yanling Gao, Xiuli Geng, Guoqi Xie, Shaojun Hao, Yan Li, Zhengchen Zhang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi journal of biological sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Effect of Marine MicroalgaMarine drugs · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xuejun KongThe 371st Central Hospital of PLA, Xinxiang 453000, China.
Yanling GaoThe 371st Central Hospital of PLA, Xinxiang 453000, China.
Xiuli GengThe 371st Central Hospital of PLA, Xinxiang 453000, China.
Guoqi XieThe 371st Central Hospital of PLA, Xinxiang 453000, China.
Shaojun HaoThe 371st Central Hospital of PLA, Xinxiang 453000, China.
Yan LiThe 371st Central Hospital of PLA, Xinxiang 453000, China.
Zhengchen ZhangThe 371st Central Hospital of PLA, Xinxiang 453000, China.
Xinxiang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Observe the effect of lipid-lowering tablets on body weight, liver index and serum biochemical indexes of hyperlipidemia rats. The hyperlipidemia rat model was replicated successfully. Compared with the model group, high, medium and low dose lipid-lowering tablets group could significantly increase the body weight of rats with hyperlipidemia (P < 0.01, P < 0.05); High and middle dose lipid-lowering tablets group could significantly reduce the liver index of high fat rat (P < 0.01); High, medium and low dose lipid-lowering tablets group could significantly decrease levels of TC, TG, LDL-C, AST, ALT, ALP, Y-GT in serum (P < 0.01, P < 0.05), and significantly increase the level of HDL-C (P < 0.01). Lipid-lowering tablets can effectively regulate the body lipid metabolism of rats, and have a certain therapeutic effect on hyperlipidemia.

Indexed as

Body weightHyperlipidemiaLipid-lowering tabletLiver indexRatsSerum biochemical index

Identifiers

PMID29740235
PMCPMC5936974
OpenAlexW2772023995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.